Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$595K Hold
1,644
0.34% 80
2026
Q1
$578K Hold
1,644
0.38% 71
2025
Q4
$538K Hold
1,644
0.37% 73
2025
Q3
$464K Hold
1,644
0.32% 77
2025
Q2
$459K Hold
1,644
0.37% 69
2025
Q1
$512K Buy
1,644
+155
+10% +$45.8K 0.51% 59
2024
Q4
$388K Buy
+1,489
New +$442K 0.43% 72

Other funds holding AMGN

M.E. Allison & Co's AMGN Position: Q2 2026 in Review

M.E. Allison & Co held its Amgen (AMGN) position steady in Q2 2026 at 1,644 shares worth $595K. The position accounts for 0.34% of the portfolio, ranked #80.

M.E. Allison & Co first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • M.E. Allison & Co held 1,644 shares of Amgen worth $595K as of Q2 2026.
  • M.E. Allison & Co left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.34% of M.E. Allison & Co's portfolio in Q2 2026, its #80 holding.
  • M.E. Allison & Co first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on M.E. Allison & Co's 13F filing for Q2 2026, filed 7 Jul 2026.